BlackRock Institutional Trust’s Anika Therapeutics ANIK Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$18.7M	Buy	382,051 +15,772	+4%	+$729K	﹤0.01%	2014
2016 Q3	$17.5M	Buy	366,279 +3,718	+1%	+$184K	﹤0.01%	1974
2016 Q2	$19.5M	Sell	362,561 -18,492	-5%	-$871K	﹤0.01%	1864
2016 Q1	$17M	Buy	381,053 +302	+0.1%	+$12.3K	﹤0.01%	1923
2015 Q4	$14.5M	Sell	380,751 -14,652	-4%	-$560K	﹤0.01%	2082
2015 Q3	$12.6M	Sell	395,403 -102,454	-21%	-$3.57M	﹤0.01%	2132
2015 Q2	$16.4M	Sell	497,857 -33,243	-6%	-$1.19M	﹤0.01%	2062
2015 Q1	$21.9M	Sell	531,100 -12,799	-2%	-$517K	﹤0.01%	1871
2014 Q4	$22.2M	Buy	543,899 +12,420	+2%	+$485K	﹤0.01%	1835
2014 Q3	$19.5M	Buy	531,479 +56,615	+12%	+$2.45M	﹤0.01%	1886
2014 Q2	$22M	Sell	474,864 -32,900	-6%	-$1.46M	﹤0.01%	1892
2014 Q1	$20.9M	Buy	507,764 +118,231	+30%	+$4.39M	﹤0.01%	1925
2013 Q4	$14.9M	Buy	389,533 +3,465	+0.9%	+$107K	﹤0.01%	2147
2013 Q3	$9.22M	Buy	386,068 +7,743	+2%	+$174K	﹤0.01%	2410
2013 Q2	$6.43M	Buy	+378,325	New	+$5.46M	﹤0.01%	2574